Colgate-Palmolive financials
$86.46−0.07%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.38B | $20.10B | $19.46B | $17.97B | $17.42B | $16.47B | $15.69B | $15.54B | $15.45B | $15.20B |
| Gross profit | $12.25B | $12.16B | $11.33B | $10.25B | $10.38B | $10.02B | $9.32B | $9.23B | $9.28B | $9.12B |
| Gross margin | 60.1% | 60.5% | 58.2% | 57.0% | 59.6% | 60.8% | 59.4% | 59.4% | 60.0% | 60.0% |
| Operating income | $3.31B | $4.27B | $3.98B | $2.89B | $3.33B | $3.88B | $3.45B | $3.61B | $3.59B | $3.84B |
| Net income | $2.13B | $2.89B | $2.30B | $1.78B | $2.17B | $2.69B | $2.37B | $2.40B | $2.02B | $2.44B |
| Net margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% |
| Diluted EPS | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 |
| EBITDA | $4.86B | $4.87B | $4.55B | $4.16B | $4.46B | $4.42B | $3.96B | $4.12B | $4.06B | $4.28B |
| Operating cash flow | $4.20B | $4.11B | $3.75B | $2.56B | $3.33B | $3.72B | $3.13B | $3.06B | $3.05B | $3.14B |
| Free cash flow | $3.63B | $3.55B | $3.04B | $1.86B | $2.76B | $3.31B | $2.80B | $2.62B | $2.50B | $2.55B |
| Diluted shares | 811.1M | 823.2M | 829.2M | 838.8M | 848.3M | 859.3M | 861.1M | 873.0M | 887.8M | 898.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.29B | $1.10B | $966.0M | $775.0M | $832.0M | $888.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $7.99B | $7.95B | $8.55B | $8.77B | $7.25B | $7.60B |
| Total assets | $16.33B | $16.05B | $16.39B | $15.73B | $15.04B | $15.92B |
| Total liabilities | $15.96B | $15.50B | $15.44B | $14.93B | $14.07B | $14.82B |
| Shareholders' equity | $365.0M | $544.0M | $957.0M | $806.0M | $971.0M | $1.10B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology